Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients

Nephrology Dialysis Transplantation

Volumn 21, Issue 4, 2006, Pages 1053-1059

  Pardon, Agathe ^a   Audard, Vincent ^a   Caillard, Sophie ^b   Moulin, Bruno ^b   Desvaux, Dominique ^a   Bentaarit, Bouteina ^a   Remy, Philippe ^a   Sahali, Dil ^a   Roudot Thoraval, Françoise ^a   Lang, Philippe ^a   Grimbert, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Acute rejection; Focal segmental glomerulosclerosis; Recurrence; Renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PEFLOXACIN; PREDNISONE; STEROID; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; DATA ANALYSIS; DIALYSIS; FEMALE; FOCAL GLOMERULOSCLEROSIS; FRANCE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTIC SYNDROME; PLASMAPHERESIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 33645308785     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfk005     Document Type: Article

References (44)

1. Ingulli E, Tejani A. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children - a single-center experience. Transplantation 1991; 51: 401-405
2. Dantal J, Baatard R, Hourmant M, Cantarovich D, Buzelin F, Soulillou JP. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects. Transplantation 1991; 52: 827-831
3. Cameron JS, Senguttuvan P, Hartley B et al. Focal segmental glomerulosclerosis in fifty-nine renal allografts from a single centre; analysis of risk factors for recurrence. Transplant Proc 1989; 21: 2117-2118
4. Dantal J, Soulillou JP. Relapse of focal segmental glomerulosclerosis after kidney transplantation. Adv Nephrol Necker Hosp 1996; 25: 91-106
5. Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis posttransplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992; 2: S258-S263
6. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: Natural history and response to therapy. Am J Med 1992; 92: 375-383
7. Savin VJ, Sharma R, Sharma M et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878-883
8. Shalhoub RJ. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 1974; 2: 556-560
9. Grimbert P, Audard V, Remy P, Lang P, Sahali D. Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant 2003; 18: 245-248
10. Gagnadoux MF, Broyer M, Habib R. Transplantation in children with idiopathic nephrosis. In: Murakami K, ed. Recent Advances in Pediatric Nephrology: Proceedings of the Seventh International Congress of Pediatric Nephrology, Tokyo, Japan, 7-12 September 1986. Amsterdam, Elsevier Science Publishers, 1987, pp. 351.
11. Kim EM, Striegel J, Kim Y, Matas AJ, Najarian JS, Mauer SM. Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejection. Kidney Int 1994; 45: 1440-1445
12. Salomon R, Gagnadoux MF, Niaudet P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 2003; 75: 810-814
13. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994; 23: 574
14. Dantal J, Bigot E, Bogers W et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994; 330: 7-14
15. Davenport RD. Apheresis treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation: Re-analysis of published case-reports and case-series. Clin Apheresis 2001; 16: 175-178
16. Striegel JE, Sibley RK, Fryd DS, Mauer SM. Recurrence of focal segmental sclerosis in children following renal transplantation. Kidney Int 1986; 19: S44-S50
17. Kim SJ, Kim M, Ha J et al. Focal segmental glomerulosclerosis progression to end-stage renal disease within 48 months is a risk factor for recurrence after pediatric renal transplantation. Transplant Proc 1999; 31: 1393-1394
18. Pinto J, Lacerda G, Cameron JS, Turner DR, Bewick M, Ogg CS. Recurrence of focal segmental glomerulosclerosis in renal allografts. Transplantation 1981; 32: 83-89
19. Rizzoni G, Ehrich JHH, Brunner FP et al. Combined report on regular dialysis and transplantation of children in Europe, 1990. Nephrol Dial Transplant 1991; 6: S31
20. Maizel SE, Sibley RK, Horstman JP, Kjellstrand CM, Simmons RL. Incidence and significance of recurrent focal segmental glomerulosclerosis in renal allograft recipients. Transplantation 1981; 32: 512-516
21. Raafat R, Travis LB, Kalia A, Diven S. Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis. Pediatr Nephrol 2000; 14: 189-194
22. Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF. Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet. 1972; 2: 343-348
23. Banfi G, Colturi C, Montagnino G, Ponticelli C. The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine. Transplantation 1990; 50: 594-596
24. Cattran DC, Appel GB, Hebert LA et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 1999; 56: 2220-2226
25. Choi KH, Kim SI, Yoon SY et al. Long-term outcome of kidney transplantation in adult recipients with focal segmental glomerulosclerosis. Yonsei Med J 2001; 42: 209-214
26. Otsubo S, Nitta K, Tanabe K et al. Maximal glomerular size as a predictor of recurrence in renal allograft recipients with focal segmental glomerulosclerosis. Nephron 2000; 84: 376-378
27. Abbott KC, Sawyers ES, Oliver JD et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001; 37: 366-373
28. Kessler M, Champigneulles J, Hestin D, Frimat L, Renoult E. A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus. Transplantation 1999; 67: 641-643
29. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 1991; 40: 453-460.
30. Cochat P, Kassir A, Colon et al. Recurrent nephrotic syndrome after transplantation: Early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol 1993; 7: 50-54
31. Sahali D, Pawlak A, Valanciute A et al. A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 2002; 13: 1238-1247
32. Andresdottir MB, Ajubi N, Croockewit S, Assmann KJ, Hibrands LB, Wetzels JF. Recurrent focal glomerulosclerosis: Natural course and treatment with plasma exchange. Nephrol Dial Transplant 1999; 14: 2650-2656
33. Laufer J, Ettenger RB, Ho WG, Cohen AH, Marik JL, Fine RN. Plasma exchange for recurrent nephrotic syndrome following renal transplantation. Transplantation 1988; 46: 540-542
34. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994; 23: 574-581
35. Belson A, Yorgin PD, Al-Uzri AY et al. Long-term plasmapheresis and protein A column treatment of recurrent FSGS. Pediatr Nephrol 2001; 16: 985-989
36. Montagnino G, Tarantino A, Banfi G et al. Double recurrence of FSGS after two renal transplants with complete regression after plasmapheresis and ACE inhibitors. Transpl Int 2000; 13: 166-168
37. Matalon A, Markowitz GS, Joseph RE et al. Appel GBPlasmapheresis treatment of recurrent FSGS in adult renal transplant recipients. Clin Nephrol 2001; 56: 271-278
38. Zimmerman SW. Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis. Nephron 1985; 40: 241-245
39. Saleem MA, Ramanan AV, Rees L. Recurrent focal segmental glomerulosclerosis in grafts treated with plasma exchange and increased immunosuppression. Pediatr Nephrol 2000; 14: 361-364
40. Pruna A, Barka A, Nochy D et al. Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients. Nephrologie 1997; 18: 95-101
41. Pruna A, Metivier F Akposso K et al. Pefloxacin as firstline treatment in nephrotic syndrome. Lancet 1992; 340: 728-729
42. Bagga A, Sharma A, Srivastava RN. Inefficacy of pefloxacin in steroid-responsive nephrotic syndrome. Pediatr Nephrol 1995; 9: 793-794
43. Cochat P, Schell M, Ranchin B, Boueva A, Said MH. Management of recurrent nephrotic syndrome after kidney transplantation in children. Clin Nephrol 1996; 46: 17-20
44. Tejani AH, Sullivan EK, Harmon WE et al. Pediatric renal transplantation-the NAPRTCS experience. Clin Transpl 1997; 87-100